CA2346406A1 - Detection de pleiotrophine - Google Patents

Detection de pleiotrophine Download PDF

Info

Publication number
CA2346406A1
CA2346406A1 CA002346406A CA2346406A CA2346406A1 CA 2346406 A1 CA2346406 A1 CA 2346406A1 CA 002346406 A CA002346406 A CA 002346406A CA 2346406 A CA2346406 A CA 2346406A CA 2346406 A1 CA2346406 A1 CA 2346406A1
Authority
CA
Canada
Prior art keywords
pleiotrophin
ptn
detection
positive
diagnosing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002346406A
Other languages
English (en)
Other versions
CA2346406C (fr
Inventor
Anton Wellstein
Boussad Souttou
Daniel Raulai
Marc Vigny
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Georgetown University
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2346406A1 publication Critical patent/CA2346406A1/fr
Application granted granted Critical
Publication of CA2346406C publication Critical patent/CA2346406C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57585—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002346406A 1998-10-06 1999-10-06 Detection de pleiotrophine Expired - Fee Related CA2346406C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10319798P 1998-10-06 1998-10-06
US60/103,197 1998-10-06
PCT/US1999/023220 WO2000020869A1 (fr) 1998-10-06 1999-10-06 Detection de pleiotrophine

Publications (2)

Publication Number Publication Date
CA2346406A1 true CA2346406A1 (fr) 2000-04-13
CA2346406C CA2346406C (fr) 2009-02-17

Family

ID=22293896

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002346406A Expired - Fee Related CA2346406C (fr) 1998-10-06 1999-10-06 Detection de pleiotrophine

Country Status (4)

Country Link
EP (1) EP1121598A4 (fr)
JP (1) JP2002526777A (fr)
CA (1) CA2346406C (fr)
WO (1) WO2000020869A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114112584A (zh) * 2021-11-19 2022-03-01 西安近代化学研究所 一种用于确定高固含量发射药熟化温度的制样工具包及使用方法

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6687601A (en) 2000-06-14 2001-12-24 Univ Georgetown Med Center Pleiotrophin growth factor receptor for the treatment of proliferative, vascularand neurological disorders
WO2002040715A2 (fr) * 2000-09-05 2002-05-23 Incyte Genomics, Inc. Molecules permettant la detection et le traitement de maladies
US20030118585A1 (en) 2001-10-17 2003-06-26 Agy Therapeutics Use of protein biomolecular targets in the treatment and visualization of brain tumors
US7888485B2 (en) 2003-03-26 2011-02-15 Georgetown University Anti-pleiotrophin antibodies and methods of use thereof
US8501473B2 (en) 2003-07-16 2013-08-06 Evotec International Gmbh Use of pleitrophin for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome
AU2005272920B2 (en) * 2004-08-10 2011-05-12 Institute For Multiple Myeloma And Bone Cancer Research Methods of regulating differentiation and treating of multiple myeloma
US20150329912A1 (en) * 2013-01-13 2015-11-19 Emory University Biomarkers in cancer, methods, and systems related thereto
PT110722B (pt) * 2018-05-03 2021-08-17 Instituto De Patologia E Imunologia Molecular Da Univ Do Porto Ipatimup Uso de anticorpos para o antigénio thomsen-friedenreich num método e estojo para avaliação de instabilidade de microsatelites

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2195450A1 (fr) * 1994-07-18 1996-02-01 Kenneth J. Colley Oligonucleotides antisens de pleiotrophine
US5876730A (en) * 1997-08-07 1999-03-02 Childrens Hospital Research Foundation Heparin-binding growth factor (HBGF) polypeptides

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114112584A (zh) * 2021-11-19 2022-03-01 西安近代化学研究所 一种用于确定高固含量发射药熟化温度的制样工具包及使用方法
CN114112584B (zh) * 2021-11-19 2023-07-18 西安近代化学研究所 一种用于确定高固含量发射药熟化温度的制样工具包及使用方法

Also Published As

Publication number Publication date
EP1121598A4 (fr) 2002-01-30
WO2000020869A1 (fr) 2000-04-13
JP2002526777A (ja) 2002-08-20
CA2346406C (fr) 2009-02-17
EP1121598A1 (fr) 2001-08-08

Similar Documents

Publication Publication Date Title
US6916626B1 (en) Detection of Candida
WO2003043487A3 (fr) Procede d'utilisation d'une proteine non anticorps permettant de detecter et de mesurer un analyte
ATE361470T1 (de) Verfahren zur diagnose von immunologischer lebensmittelsensitivität
IL143892A0 (en) Kidney disease detection and treatment
BG104275A (en) Method and device for express analysis of tested parameters in biological samples
CA2214488A1 (fr) Dosage du cpsa
GB9804083D0 (en) Immunoassays
AU2849300A (en) Methods and assay kits for detecting mononuclear cell phenotype
AU2003260457A1 (en) A method and kit for the quantitative and/or qualitative detection of components in a sample
CA2464466A1 (fr) Procede et appareil permettant de differencier la maladie de crohn d'autres troubles gastro-intestinaux tels que la rectocolite ulcero-hemorhagique ou le syndrome du colon irritable, par detection de la presence d'anticorps fecaux anti-saccharomyces cerevisiae
EP1214447B8 (fr) Determination de la presence d'isoenzymes de la pyruvate kinase dans les selles
DE19806185C2 (de) Immunoassay und Testkit zur Bestimmung von fucosyliertem Protein in einer biologischen Probe
AU2002233800A1 (en) Method and kit for predicting cancer
CA2361000A1 (fr) Inhibiteur de trypsine urinaire permettant de depister le sida
EP1159614A4 (fr) Methodes diagnostiques de l'asthme
CA2366651A1 (fr) Procede de detection de proteine megsine et son utilisation
WO2006004958A3 (fr) Detection ou mesure d'anticorps par rapport a proteines antigenes dans des tissus ou des echantillons biologiques
WO1998029726A3 (fr) Procede de detection de la troponine i et de determination de sa concentration totale dans un echantillon biologique
CA2358504A1 (fr) Methodes de determination de risque augmente pour une femme portant un foetus atteint du syndrome de down en mesurant un analyte dans un prelevement biologique
WO2001027621A3 (fr) DOSAGE IMMUNOENZYMATIQUE D'INHIBITION (iELISA) PERMETTANT DE DETECTER ET QUANTIFIER LES ANTICORPS PRESENTS DANS DES PRELEVEMENTS BIOLOGIQUES
DE60038557D1 (en) Assay
JP5048207B2 (ja) 敗血症状態の発症および存在を決定するための装置及び方法
EP0439213B1 (fr) Un essai d'attache directe pour la détermination d'organismes Bactéroides
RU2197736C1 (ru) Реагент для иммуноферментного анализа и способ иммуноферментного тестирования специфических антител при описторхозе, вызываемом печеночной трематодой opisthorhis felineus
RU2157540C2 (ru) Способ определения или обнаружения повреждения органа-донора после ксенотрансплантации на основе анализа веществ, полученных из органа-донора

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20141006